FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

Atom Transfer Radical Polymerization (ATRP)

DNA-Stable Isotope Probing Technology (DNA-SIP)

Analyzing Protein Structures with Pronalyse’s Hydrogen Deuterium Exchange Mass Spectrometry

Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

Creative Proteomics Launches SPR-based Biacore Service to Help Study Biomolecular Interactions

CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research

Alfa Chemistry Commenced Offering PTFE (Polytetrafluoroethylene), Optical Fibers, and Diamond Raw Materials

Startup OncoDxRx harnesses the power of proprietary liquid biopsy technologies for better clinical diagnostics and therapeutics

New Startup OncoDxRx showcases its one-of-a-kind Dx technologies for oncology market

Creative Enzymes Offers Personalized and Customized Probiotic Blends

Creative Enzymes Introduces Cloning Enzymes for Molecular Biology Research

Oxygen-, Nitrogen-, Carbon-Donor Ligands for Coordination Chemistry Research

Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

Alfa Chemistry Celebrates Thanksgiving Day and Christmas with Festival Sale for All Products and Services

API Supply Enriched by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation

Blue Spark Technologies Touts Growth for Company and Remote Patient Monitoring Industry

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, celebrated a successful year of achievements with its continuous temperature monitoring solution TempTraq®. Numerous studies were released this year showing the positive impact of TempTraq in oncology clinical trials and outpatient settings.

Energy reduction measures including AI are now needed to avoid energy shortage in 2023!

Arloid Automation welcomes the new partnership between the UK and the USA (announced December 2022) to drive down energy prices but really it’s a reduction in energy consumption that’s needed to meet demand in 2023.

Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma.